Susan Silbermann

in page functions

President and General Manager, Pfizer Vaccines, USA

Susan Silbermann

Susan Silbermann is the President and General Manager of Pfizer Vaccines. In her role, she oversees a global business and is responsible for the commercial development of a visionary pipeline portfolio of preventative and therapeutic vaccines to address unmet medical needs and treat serious or life-threatening conditions. Ms Silbermann leads a team that partners with government and global civic organisations to maximise Pfizer’s impact on public health. Prior to this position, Ms Silbermann was the Regional President of Latin America within Pfizer’s Emerging Markets Business Unit. In this role, she managed Pfizer’s pharmaceutical operations in a diverse market with more than 20 countries. Throughout her nearly 30-year career at Pfizer, Ms Silbermann has held numerous leadership positions in Marketing, Commercial Development and General Management in the USA and international markets.

Ms Silbermann holds a seat on the International Federation of Pharmaceutical Manufacturers & Associations Vaccine CEO Steering Committee. In addition, she serves on the Boards of Advisors for Catalyst Inc., a nonprofit organisation that promotes inclusive workplaces for women, and on the Corporate Advisory Board for the Johns Hopkins University Carey Business School (USA).

Ms Silbermann has a BS in Biology and French from Tufts University (USA), and a joint MBA/MA degree in International Business and French studies from the Stern Graduate School of Business (USA) and the Institute of French Studies at New York University (USA).

 

close icon

modal window here